FDA news in pedatrics: April 2025
A look back at the FDA submissions and regulatory decisions in the pediatric health care space from April 2025.
Food Insecurity and the Dangers of Infant Formula Dilution
Uncovering the pediatrician's role in OTC STI testing, with Lea Widdice, MD
Lea Widdice, MD, details her recent presentation at PAS 2025 on OTC STI testing within pediatrics.
Demystifying Infant Formula
FDA approves nipocalimab-aahu to treat generalized myasthenia gravis
The human FcRn-blocking monoclonal antibody is indicated for gMG patients aged 12 years and older.
Zika-based therapy for metastatic neuroblastoma with Tamarah Westmoreland, MD and Joseph Mazar, PhD
A PAS 2025 study by Mazar and Westmoreland shows Zika virus can eliminate both local and distant tumors in neuroblastoma mouse models.
